AtaiBeckley Inc.·4

Jun 29, 6:00 PM ET

Craig Kevin James 4

Research Summary

AI-generated summary

Updated

AtaiBeckley (ATAI) CMO Craig James Exercises Options, Sells Shares

What Happened
Craig Kevin James, Chief Medical Officer of AtaiBeckley Inc. (ATAI), exercised a total of 42,579 option shares and sold the same 42,579 shares on June 25, 2026. He exercised 33,051 options at $1.50 (cost $49,577) and 9,528 options at $1.18 (cost $11,243), for total exercise cash paid of $60,820. He then sold those 42,579 shares in open-market transactions at a weighted average price of $4.51, receiving about $192,031 in proceeds.

Key Details

  • Transaction date: 2026-06-25 (Form filed 2026-06-29 — appears timely; two-business-day filing window).
  • Exercises: 33,051 shares @ $1.50 (total $49,577) and 9,528 shares @ $1.18 (total $11,243).
  • Sale: 42,579 shares sold at a weighted average price $4.51; reported sale range $4.50–$4.54; total proceeds ≈ $192,031 (footnote F2).
  • Post-transaction shares beneficially owned: not disclosed in the data provided in this summary (not specified in the supplied items).
  • Footnotes: trades executed under a Rule 10b5‑1 trading plan adopted Dec 19, 2025 (F1). Vesting schedules noted for the options (F3, F4).

Context
The filing shows a same‑day exercise of options followed by sale of the acquired shares — effectively a cashless exercise (exercise + immediate disposition). M-coded entries indicate option exercises; the $0 “disposition” lines correspond to the derivative (option) being converted/exercised. The 10b5‑1 plan note means the trades were prearranged under an affirmative defense plan rather than ad hoc market timing. This appears to be a routine monetization of vested options rather than an open-market purchase signaling increased insider confidence.